• Medication response: Unexpected side effects, reduced efficacy or poor tolerance to prescribed treatments.
• Polypharmacy: Use of multiple medications with potential interaction or metabolic considerations.
• Psychiatric medication response: Variable response to antidepressants, antipsychotics or mood stabilisers.
• Cardiometabolic treatment: Medication use for cardiovascular conditions, diabetes or lipid regulation.
• Pain management: Limited response or adverse reactions to analgesics or anti-inflammatory drugs.
• Dose optimisation: Exploring whether genetic variation may influence standard dosing.
• Pre-treatment planning: Starting long-term medication.
• Adverse drug reactions: Previous intolerance, toxicity or treatment discontinuation.
• Preventive medication review: Interest in safer long-term prescribing approaches.

Medcheck® is a DNA-based pharmacogenomic test to analyse genetic variations affecting drug metabolism pathways and treatment responsiveness. The panel focuses on functional biological systems that influence how medications are absorbed, activated, transported and eliminated, helping practitioners explore inherited differences that may shape therapeutic outcomes.

The test considers genetic influences across key enzyme systems, transporter activity and receptor-level response mechanisms involved in multiple therapeutic areas including cardiometabolic care, psychiatry, pain management, gastroenterology and immunomodulatory treatment. Variation in these pathways may contribute to differences in drug exposure, treatment effectiveness or susceptibility to adverse effects. The report utilises a 'at a glance' reporting style, alongside more detailed information to assess the patients unique response to medications allowing very clear management of medications for optimal and safe outcomes.

Results are interpreted alongside clinical diagnosis, medication history, symptom response and overall treatment goals. Integrating pharmacogenomic insight with medical context can support more informed discussion around medication selection, dosing considerations and longer-term treatment monitoring.

Sample required:

Blood Spot

Average processing time:

21 days